| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/21/1993 | US5246700 In patients suffering from malignant tumors, interleukin-4 |
| 09/21/1993 | CA1322367C Thienotriazolodiazepine compounds and pharmaceutical uses thereof |
| 09/19/1993 | CA2091866A1 Agent for treatment of chronic fatigue syndrome |
| 09/19/1993 | CA2091214A1 Pyrimidine derivatives |
| 09/16/1993 | WO1993018141A1 Thrombin receptor antagonists |
| 09/16/1993 | WO1993018040A1 Cyclic ketal derivatives |
| 09/16/1993 | WO1993018039A1 Cyclic ketal derivatives |
| 09/16/1993 | WO1993018032A1 Indole derivatives as 5-ht1 agonists |
| 09/16/1993 | WO1993017991A1 TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS |
| 09/16/1993 | WO1993017684A2 Enantiomeric hydroxylated xanthine compounds |
| 09/16/1993 | WO1993017670A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 09/16/1993 | CA2131801A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 09/16/1993 | CA2131389A1 Thrombin receptor antagonists |
| 09/16/1993 | CA2131010A1 Cyclic ketal derivatives |
| 09/15/1993 | EP0560284A1 Prophylactic and remedial preparation for diseases attendant on hyperglycemia, and wholesome food |
| 09/15/1993 | EP0560275A1 Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients |
| 09/15/1993 | EP0559884A1 Viral recombinant vectors for expression in muscle cells |
| 09/15/1993 | EP0559751A1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth). |
| 09/15/1993 | EP0409971B1 Weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin |
| 09/15/1993 | EP0397831B1 Treatment of obesity |
| 09/14/1993 | US5245050 Anticholesterol agents |
| 09/14/1993 | US5244915 Amico acid derivatives cyclized at the c-terminal |
| 09/14/1993 | US5244898 Benzoheterocyclic compounds |
| 09/14/1993 | US5244889 Treatment of cardiovascular disorders |
| 09/14/1993 | CA1322165C Method for treating iron overload |
| 09/08/1993 | EP0559571A1 Thiazolidine-2,4-dione derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/08/1993 | EP0559055A1 N-Deacetyl lysogangliosides for use as medicaments |
| 09/08/1993 | EP0558727A1 Bone-growth-stimulating composition |
| 09/08/1993 | EP0558679A1 Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
| 09/08/1993 | EP0437523B1 Triglycerides, nutritional composition comprising such triglycerides, and use of the nutritional composition for nutrition |
| 09/08/1993 | EP0297117B1 Biologically active agent |
| 09/08/1993 | CN1022024C Vitamine-containing granules and production method thereof |
| 09/07/1993 | US5242937 Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors |
| 09/07/1993 | US5242912 Cyclic anthranilic acid derivatives and process of preparing the same |
| 09/07/1993 | CA2091127A1 Thiazolidine-2,4-dione derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/07/1993 | CA1322077C Process for synthesis of aminomethylene phosphonoalkylphosphinates |
| 09/07/1993 | CA1321994C Acylated uridine and cytidine and uses thereof |
| 09/02/1993 | WO1993017038A1 Methods of treating diabetes |
| 09/02/1993 | WO1993016724A1 Bystander suppression of autoimmune diseases |
| 09/02/1993 | WO1993016700A1 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and ×dema |
| 09/02/1993 | WO1993016598A1 Effect of particle-size distribution of cellulose ethers on palatability of compositions |
| 09/02/1993 | WO1993016595A1 Nutritional product for trauma and surgery patients |
| 09/02/1993 | CA2130182A1 Methods of treating diabetes |
| 09/01/1993 | EP0558468A1 Medicament for inhibiting nitric oxide formation |
| 09/01/1993 | EP0558416A1 New 17-(methylene)-lactone spiro condensed steroids, method and intermediates for their production, their use as medicines and pharmaceutical compositions containing them |
| 09/01/1993 | EP0558213A1 Process for preparing neotrehalose, and its uses |
| 09/01/1993 | EP0557939A1 Aldose reductase inhibitor |
| 09/01/1993 | EP0557879A1 4-amino-2-ureido-5-pyrimidincarboxamide, process for their preparation, medicines containing those compounds and their use |
| 09/01/1993 | EP0557877A1 Soluble salts of 4-amino-2-(4,4-dimethyl-imidazolidin-2-on-1-yl)-pyrimidin-5-carboxylic acid N-methyl-N-(3-trifluoromethyl-phenyl)-amide, process for their preparation, their use as medicine and initial products |
| 09/01/1993 | EP0557498A1 Bone-growth-stimulating composition |
| 09/01/1993 | CN1075714A Alpha-aryl-alpha-hydroxy-beta-imidazolinyl-propionamides |
| 08/31/1993 | US5240962 Alkyl or alkenyl-phenols |
| 08/31/1993 | US5240958 Treating rheumatoid arthritis, promoting wound healing |
| 08/31/1993 | US5240950 Carbazate derivatives, their production and use |
| 08/31/1993 | US5240911 Method of reducing blood sugar levels using a hypoglycemic agent |
| 08/31/1993 | US5240714 Non-digoxin-like Na+, K+ -ATPase inhibitory factor |
| 08/31/1993 | US5240696 Treatment of periodontitis |
| 08/31/1993 | CA1321793C Bicyclic diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| 08/31/1993 | CA1321792C Piperidine opioid antagonists |
| 08/31/1993 | CA1321791C Preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains |
| 08/29/1993 | CA2090743A1 Pharmaceutical compounds |
| 08/26/1993 | CA2089241A1 Process for preparing neotrehalose, and its uses |
| 08/25/1993 | EP0557171A1 Azaindoles, process for their preparation and medicines containing them |
| 08/25/1993 | EP0557148A1 Process for the preparation of a dietary supplement from embryonic tissues |
| 08/25/1993 | EP0557075A1 4H-naphtho 1,2-b pyran derivatives as antiproliferative agents |
| 08/25/1993 | EP0556674A1 3,5-substituted benzoylguanidines with antiarrhythmic activity and cell proliferation inhibiting activity |
| 08/25/1993 | EP0556673A1 Ortho-substituted benzoylguanidines for the treatment and prophylaxis of heart-rhythm disorders and ischaemically induced damage, as well as inhibition of cell proliferation |
| 08/25/1993 | EP0556672A1 Amino-substituted benzoylguanidines with antiarrhythmic properties |
| 08/25/1993 | EP0556395A1 Novel cytokine |
| 08/25/1993 | EP0556204A1 Pharmaceutical composition containing an ace inhibitor and an inhibitor of thromboxane a2 activity for treating nephropathies |
| 08/23/1993 | CA2089956A1 Soluble salts of 4-amino-2-(4,4-dimethylimidazolidin-2-on-1-yl)-pyrimidine-5-carboxylic acid n-methyl-n-(3-trifluoromethylphenyl)amide, a process for the preparation thereof, the use thereof as pharmaceuticals and starting materials |
| 08/20/1993 | CA2089974A1 Pharmaceutical compounds |
| 08/19/1993 | WO2003016307A1 β3 ADRENERGIC AGONISTS |
| 08/19/1993 | WO1993016105A1 Phenylalanine analogs of bombesin |
| 08/19/1993 | WO1993016067A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 08/19/1993 | WO1993016055A1 Hypolipidaemic benzothiazepine compounds |
| 08/19/1993 | WO1993016029A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
| 08/19/1993 | WO1993015109A3 Parathyroid hormone fragments, their preparation and medicaments containing the same |
| 08/19/1993 | CA2129831A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 08/19/1993 | CA2129830A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
| 08/19/1993 | CA2129032A1 Phenylalanine analogs of bombesin |
| 08/19/1993 | CA2117485A1 Hypolipidaemic benzothiazepine compounds |
| 08/19/1993 | CA2086910A1 Food supplement preparation process using microseptor-type mesenchymal substances |
| 08/18/1993 | EP0556083A1 Process for the production of biologically active substances from milk and related raw materials |
| 08/18/1993 | EP0555845A2 Steroid derivatives |
| 08/18/1993 | EP0555327A1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo |
| 08/18/1993 | EP0555264A1 Novel compounds |
| 08/18/1993 | EP0555251A1 Thiazolidine dione derivatives |
| 08/18/1993 | EP0555249A1 Thiazolidinedione derivatives |
| 08/18/1993 | EP0425482B1 Human insulin analogs and preparations containing them |
| 08/18/1993 | EP0339075B1 Acylated uridine and cytidine and uses thereof |
| 08/18/1993 | EP0262178B1 Amino acid chelated compositions for delivery to specific biological tissue sites |
| 08/18/1993 | CN1021823C Process for substituted benzodihydropyran compound for treating asthma, arthritis and other diseases |
| 08/18/1993 | CN1021790C Improvements in or relating to a method for increasing the feed intake of an animal |
| 08/17/1993 | US5236933 Use of a combination of angiotensin-converting enzyme inhibitor and calcium antagonist for the treatment of proteinuria |
| 08/15/1993 | CA2089470A1 Azaindoles, preparation processes and medicinal products containing them |
| 08/11/1993 | EP0554861A1 The use of inositoltriphosphate for the treatment of renal diseases |
| 08/11/1993 | EP0417238B1 Silicon-containing environment-protective agent adsorbing radioactive metal isotopes and toxic heavy metals and a pharmaceutical composition containing same |
| 08/10/1993 | US5235065 Process for the preparation of a d-(+)-biotin intermediate |
| 08/10/1993 | US5234956 Reducing increase in calcium ion concenration; administering nitroglycerin, nitroprusside or derivatives thereof; treating AIDS, Alzheimer's, CNS disorders, cardiovascular disorders |